Cohort 1 (N=379) | Cohort 2 (N=247) | |||||||||||||
Marker | CD11b | CD68 | HLA-DR | N | CD11b | CD68 | HLA-DR | N | ||||||
Age | ||||||||||||||
<65 | 29,798 | p=0.23 | 3672 | p=0.75 | 17,699 | p=0.04 | 157 | 17,334 | p=0.27 | 13,224 | p=0.92 | 7215 | p=0.70 | 115 |
>65 | 32,793 | 3720 | 16,052 | 211 | 18,075 | 1415 | 8180 | 132 | ||||||
Gender | ||||||||||||||
Male | 33,100 | p=0.04 | 3720 | p=0.84 | 17,231 | p=0.76 | 173 | 17,999 | p=0.28 | 1420 | p=0.13 | 8049 | p=0.42 | 196 |
Female | 29,870 | 3672 | 17,086 | 199 | 16,557 | 1140 | 7842 | 31 | ||||||
Histology | ||||||||||||||
ADC | 32,987 | p=0.0001 | 3840 | p=0.008 | 17,247 | p>0.99 | 202 | 18,905 | p=0.0002 | 1505 | p=0.22 | 8728 | p=0.10 | 87 |
SCC | 51,473 | 4766 | 17,288 | 86 | 28,003 | 1813 | 10,009 | 111 | ||||||
Other | 36,230 | 3683 | 15,053 | 72 | 20,767 | 1253 | 7764 | 30 | ||||||
Smoking | ||||||||||||||
Ever smoker | 32,387 | p=0.09 | 3815 | p=0.05 | 16,836 | p=0.83 | 296 | 17,897 | p=0.77 | 1422 | p=0.72 | 8160 | p=0.62 | 183 |
Never smoker | 28,103 | 3135 | 17,228 | 44 | 19,449 | 1390 | 8485 | 19 | ||||||
Stage | ||||||||||||||
I–II | 32,527 | p=0.74 | 3797 | p=0.59 | 17,482 | p=0.16 | 279 | 19,763 | p=0.97 | 1591 | p=0.95 | 10,483 | p=0.82 | 136 |
III–IV | 31,667 | 3537 | 17,057 | 72 | 22,453 | 1749 | 9524 | 87 |
ADC, adenocarcinomas; SCC, squamous cell carcinomas.